home / stock / love:cc / love:cc quote
Last: | $0.12 |
---|---|
Change Percent: | 0.0% |
Open: | $0.12 |
Close: | $0.12 |
High: | $0.12 |
Low: | $0.115 |
Volume: | 201,758 |
Last Trade Date Time: | 05/06/2022 04:56:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.12 | $0.12 | $0.12 | $0.12 | $0.115 | 201,758 | 05-06-2022 |
$0.12 | $0.12 | $0.12 | $0.12 | $0.115 | 80,320 | 05-05-2022 |
$0.115 | $0.105 | $0.115 | $0.115 | $0.105 | 297,287 | 05-04-2022 |
$0.105 | $0.115 | $0.105 | $0.115 | $0.105 | 237,248 | 05-03-2022 |
$0.11 | $0.12 | $0.11 | $0.12 | $0.105 | 202,228 | 05-02-2022 |
$0.115 | $0.115 | $0.115 | $0.115 | $0.11 | 279,942 | 04-29-2022 |
$0.12 | $0.115 | $0.12 | $0.12 | $0.115 | 166,805 | 04-28-2022 |
$0.115 | $0.11 | $0.115 | $0.115 | $0.105 | 164,246 | 04-27-2022 |
$0.11 | $0.105 | $0.11 | $0.11 | $0.105 | 68,362 | 04-26-2022 |
$0.11 | $0.115 | $0.11 | $0.115 | $0.105 | 110,958 | 04-25-2022 |
$0.115 | $0.11 | $0.115 | $0.115 | $0.105 | 172,043 | 04-22-2022 |
$0.115 | $0.115 | $0.115 | $0.115 | $0.11 | 66,409 | 04-21-2022 |
$0.115 | $0.115 | $0.115 | $0.115 | $0.11 | 432,658 | 04-20-2022 |
$0.11 | $0.115 | $0.11 | $0.115 | $0.105 | 211,452 | 04-19-2022 |
$0.11 | $0.115 | $0.11 | $0.115 | $0.11 | 78,522 | 04-18-2022 |
$0.115 | $0.115 | $0.115 | $0.115 | $0.11 | 367,583 | 04-15-2022 |
$0.115 | $0.115 | $0.115 | $0.115 | $0.11 | 367,583 | 04-14-2022 |
$0.115 | $0.11 | $0.115 | $0.115 | $0.11 | 224,204 | 04-13-2022 |
$0.115 | $0.115 | $0.115 | $0.115 | $0.105 | 480,438 | 04-12-2022 |
$0.12 | $0.115 | $0.12 | $0.12 | $0.115 | 486,751 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Cannara Biotech Inc. Company Name:
LOVE:CC Stock Symbol:
TSXVC Market:
Cannara Biotech Reports Q2 2024 Financial Results Canada NewsWire Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4...
--News Direct-- Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the cannabis industry. Cannara, based in Montreal, Canada, is a licensed producer with two facilities totaling 1.6 million square fee...
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion Canada NewsWire Record Q1 net revenues of $19.5 million , representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023 Q1 operat...